Related Experiment Video

Updated: Aug 13, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment

Nicolas Magné1, Robert-Alain Toillon, Virginie Bottero

  • 1Département de Radiothérapie, Institut Jules Bordet, 121 Boulevard de Waterloo, 1000 Bruxelles, Belgique. nicolas_magne@hotmail.com

Cancer Letters
|January 10, 2006
PubMed

Insights

NF-kappaB transcription factor plays a key role in cancer by preventing cell death. Inhibiting NF-kappaB enhances cancer cell sensitivity to therapies like radiotherapy, increasing treatment effectiveness.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Nuclear factor kappa B (NF-kappaB) is a transcription factor regulating immune responses, inflammation, cell proliferation, and apoptosis.
  • NF-kappaB plays a significant role in tumorigenesis due to its potent anti-apoptotic functions in cancer cells.
  • Cancer therapies like chemotherapy and radiotherapy activate NF-kappaB, potentially counteracting their intended apoptotic effects.

Purpose of the Study:

  • To review current knowledge on NF-kappaB regulation.
  • To discuss the therapeutic potential of targeting NF-kappaB in cancer treatment, particularly in conjunction with radiotherapy.

Main Methods:

  • Literature review of studies on NF-kappaB regulation and its role in cancer.
  • Analysis of research demonstrating the effects of NF-kappaB inhibition on cancer cell apoptosis.
  • Examination of the interplay between NF-kappaB and conventional cancer therapies.

Main Results:

  • NF-kappaB inhibition increases cancer cell sensitivity to apoptotic stimuli, including TNFalpha, chemotherapy, and radiotherapy.
  • Targeting NF-kappaB can enhance the efficacy of conventional cancer treatments.
  • The concept of combining NF-kappaB blockade with standard therapies to improve outcomes has emerged.

Conclusions:

  • NF-kappaB blockade represents a promising strategy to potentiate the effects of radiotherapy and other cancer treatments.
  • Understanding NF-kappaB regulation is crucial for developing novel therapeutic approaches in oncology.
  • Targeting NF-kappaB could overcome resistance mechanisms and improve patient outcomes in various cancers.

More Related Videos

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...